<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">RUDN Journal of Medicine</journal-id><journal-title-group><journal-title xml:lang="en">RUDN Journal of Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российского университета дружбы народов. Серия: Медицина</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-0245</issn><issn publication-format="electronic">2313-0261</issn><publisher><publisher-name xml:lang="en">Peoples’ Friendship University of Russia named after Patrice Lumumba (RUDN University)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">18443</article-id><article-id pub-id-type="doi">10.22363/2313-0245-2018-22-1-92-101</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ALLERGOLOGY. DERMATOLOGY. PULMONOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>АЛЛЕРГОЛОГИЯ. ДЕРМАТОЛОГИЯ. ПУЛЬМОНОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Especially diseases of the cardiovascular system in patients with severe and medium-severe plaque psoriasis</article-title><trans-title-group xml:lang="ru"><trans-title>Особенности заболеваний сердечно-сосудистой системы у больных тяжелыми и средне-тяжелыми формами псориаза</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Batkaeva</surname><given-names>N V</given-names></name><name xml:lang="ru"><surname>Баткаева</surname><given-names>Надежда Владимировна</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD, assistant professor, Faculty of advanced training of medical workers of the Peoples’ Friendship University of Russia (RUDN University)</p></bio><bio xml:lang="ru"><p>к.м.н., доцент, факультет повышения квалификации медицинских работников ФГАОУ ВО «Российский университет дружбы народов»</p></bio><email>nbatkaeva.derm@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Batkaev</surname><given-names>E A</given-names></name><name xml:lang="ru"><surname>Баткаев</surname><given-names>Э А</given-names></name></name-alternatives><email>nbatkaeva.derm@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gitinova</surname><given-names>M M</given-names></name><name xml:lang="ru"><surname>Гитинова</surname><given-names>М М</given-names></name></name-alternatives><email>nbatkaeva.derm@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Malyarenko</surname><given-names>E N</given-names></name><name xml:lang="ru"><surname>Маляренко</surname><given-names>Е Н</given-names></name></name-alternatives><email>nbatkaeva.derm@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Golovinov</surname><given-names>A I</given-names></name><name xml:lang="ru"><surname>Головинов</surname><given-names>А И</given-names></name></name-alternatives><email>nbatkaeva.derm@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Peoples’ Friendship University of Russia (RUDN University)</institution></aff><aff><institution xml:lang="ru">Российский университет дружбы народов</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Treatment and Rehabilitation Clinical Center of the Ministry of Defense of the Russian Federation</institution></aff><aff><institution xml:lang="ru">Лечебно-реабилитационный клинический центр Министерства обороны Российской Федерации</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2018</year></pub-date><volume>22</volume><issue>1</issue><issue-title xml:lang="en">VOL 22, NO1 (2018)</issue-title><issue-title xml:lang="ru">ТОМ 22, №1 (2018)</issue-title><fpage>92</fpage><lpage>101</lpage><history><date date-type="received" iso-8601-date="2018-05-01"><day>01</day><month>05</month><year>2018</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Batkaeva N.V., Batkaev E.A., Gitinova M.M., Malyarenko E.N., Golovinov A.I.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Баткаева Н.В., Баткаев Э.А., Гитинова М.М., Маляренко Е.Н., Головинов А.И.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Batkaeva N.V., Batkaev E.A., Gitinova M.M., Malyarenko E.N., Golovinov A.I.</copyright-holder><copyright-holder xml:lang="ru">Баткаева Н.В., Баткаев Э.А., Гитинова М.М., Маляренко Е.Н., Головинов А.И.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.rudn.ru/medicine/article/view/18443">https://journals.rudn.ru/medicine/article/view/18443</self-uri><abstract xml:lang="en"><p>Background. Psoriasis is a chronic inflammatory disease that associated with a decrease in life expectancy mostly due to cardiovascular disease. But prevalence of cardiovascular comorbidity in psoriasis patients has limited data. Objectives. To compare the prevalence of cardiovascular comorbidity in a hospital-treated cohort patients with severe psoriasis and psoriatic arthritis. Methods. 890 patients (M. - 516/F. - 347) with severe plaque psoriasis mean duration 25.7 ± 16.6 years, mean age of patients were 51.9 ± 11.6 years accordingly were included. Psoriasis patients with cardiovascular disease, including coronary heart disease, arterial hypertension, atherosclerosis and cerebrovascular accident were identify in the hospital Database reporting and coding by International Statistical Classification of Disease and Related Health Problems (ICD-10) between 2010-2015 years. M ± m, t-test, (%) were calculated. All p &lt; 0.05 were considered to indicate statistical significance. Results. Male and Female patients were at the same age. 303 out of 890 patients (34.0%) had psoriatic arthritis, 587 out of 890 patients (66.0%) had severe plaque psoriasis with mean PASI 49.4 ± 0.5. 516 out of 890 patients (59.0%) had cardiovascular disease. Cardiovascular disease coding as I 00-I 99 were found significantly often in patients with psoriatic arthritis compare to patients with psoriasis - in 206 out of 303 patients (68.2%) and in 310 out of 587 patients (52.8%) accordingly (p &lt; 0.05). Arterial hypertension coding as I 10-I 15 were found in significantly more cases in patients with psoriatic arthritis compare to patients with psoriasis - in 206 out of 303 patients (68.2%) and in 310 out of 587 patients (52.8%) accordingly (p &lt; 0.05). Coronary heart disease and atherosclerosis coding as I 70 were found in significantly more cases in patients with psoriatic arthritis compare to patients with psoriasis - in 129 out of 303 patients (42.7%) and in 205 out of 587 patients (34.9%) accordingly (p &lt; 0.05). Cerebrovascular accident coding as I 65 - I 66 were found in significantly more cases in patients with psoriatic arthritis compare to patients with psoriasis - in 50 out of 303 patients (16.6%) and in 64 out of 587 patients (10.9%) accordingly. Conclusions. Psoriatic arthritis and cardiovascular comorbidities are common for hospital-treated cohort patients. Patients with severe plaque psoriasis and psoriatic arthritis tend to suffer from cardiovascular disease and arterial hypertension.</p></abstract><trans-abstract xml:lang="ru"><p>Актуальность. Псориаз, кроме поражения кожи, характеризуется разнообразной коморбидной патологией, в первую очередь сердечно-сосудистой системы. Данные о распространенности заболеваний сердечно-сосудистой системы при псориазе и псориатическом артрите ограничены. Цель: изучить распространенность и структуру заболеваний сердечно-сосудистой системы у молодых больных с тяжелыми формами псориаза и с псориатическим артритом. Материал и методы. Проведен ретроспективный анализ медицинской документации 890 больных с тяжелыми формами псориаза (мужчин/женщин - 516/347, средний возраст пациентов 51,9 ± 11,6 года), средняя длительность псориаза 11,6 ± 0,6 (минимум 1 год - максимум 35 лет), находившихся на стационарном лечении в «Филиале Короленко» МНПЦДК за период 2010-2015 гг. У большинства включенных в исследование (71,3%) индекс тяжести псориаза PASI составил от 45 до 60 баллов (PASI 49,4 ± 0,5). Анализ заболеваемости сердечно-сосудистой системы выполняли в соответствии с кодами Международной классификации болезней 10 пересмотра. У больных псориазом зарегистрированы артериальная гипертензия (код МКБ - I10-I15), ишемическая болезнь сердца (I20-I25), атеросклероз (I70) и цереброваскулярные нарушения (I65-I66). Для статистического анализа проводился расчет M, σ, ±m, Хи-квадрат. Результаты исследования. У 303 (34,0%) пациентов был диагностирован псориатический артрит. Общее число пациентов с патологией сердечно-сосудистой системы составило 516 человек (59,0%). В структуре заболеваний сердечно-сосудистой системы у больных с псориатическим артритом чаще регистрировалась артериальная гипертензия, чем у больных с псориазом - у 68,2 и у 52,8% соответственно. Ишемическая болезнь сердца и атеросклероз чаще встречались у больных с псориатическим артритом, чем у больных с псориазом - у 42,7 и 34,9% соответственно (p &lt; 0,05). Цереброваскулярные нарушения чаще встречалась у больных с псориатическим артритом, чем у больных с псориазом - у 16,6 и у 10,9% соответственно (p &lt; 0,05). Выводы. Заболевания сердечно-сосудистой системы регистрируются более чем у половины больных с тяжелыми формами псориаза и псориатическим артритом. Среди заболеваний этой группы лидирует артериальная гипертензия. Ишемическая болезнь сердца и атеросклероз также встречаются весьма часто во всех группах больных.</p></trans-abstract><kwd-group xml:lang="en"><kwd>psoriasis</kwd><kwd>psoriatic artritis</kwd><kwd>cardiovascular comorbidity</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>псориаз</kwd><kwd>псориатический артрит</kwd><kwd>кардиоваскулярная сопутствующая патология</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Machado-Pinto J.M., Diniz M.S., Bavoso N.C. Psoriasis: new comorbidities. An Bras Dermatol. 2016;91(1):08—16.</mixed-citation><mixed-citation xml:lang="ru">Machado-Pinto J.M., Diniz M.S., Bavoso N.C. Psoriasis: new comorbidities // An Bras Dermatol. 2016;91(1): 08-16.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Nawaf AL-MUTAIRI, Shahat AL-FARAG, Ahmed AL-MUTAIRI, Mazen AL-SHILTAWY. Comorbidities associated with psoriasis: An experience from the Middle East. Journal of dermatology. 2010; 37: 146—155.</mixed-citation><mixed-citation xml:lang="ru">Nawaf AL-MUTAIRI, Shahat AL-FARAG, Ahmed AL-MUTAIRI, Mazen AL-SHILTAWY. Comorbidities associated with psoriasis: An experience from the Middle East // Journal of dermatology. 2010; 37:146-155.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Gulliver W.P. Genetic targets for the future treatment of psoriasis including HLA-Cw6. Presented at: 21st World Congress of Dermatology, 30 September — 5 October 2007, Buenos Aires, Argentina.</mixed-citation><mixed-citation xml:lang="ru">Gulliver W.P. Genetic targets for the future treatment of psoriasis including HLA-Cw6 // Presented at: 21st World Congress of Dermatology, 30 September - 5 October 2007, Buenos Aires, Argentina.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">O’Reilly D.D. Rahman P. Genetic, Epigenetic and Pharmacogenetic Aspects of Psoriasis and Psoriatic Arthritis. Rheum Dis Clin North Am. 2015;41(4):623—42. doi: 10.1016/j.rdc.2015.07.002.</mixed-citation><mixed-citation xml:lang="ru">O’Reilly D.D. Rahman P. Genetic, Epigenetic and Pharmacogenetic Aspects of Psoriasis and Psoriatic Arthritis // Rheum Dis Clin North Am. 2015;41(4):623-42. doi: 10.1016/j.rdc.2015.07.002.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Egeberg А., Mallbris L., Warren R.B. et al. Association between psoriasis and inflammatory bowel disease: a Danish nationwide cohort study. British Journal of Dermatology. (2016) 175, pp. 487—492. DOI 10.1111/bjd.14528.</mixed-citation><mixed-citation xml:lang="ru">Egeberg А., Mallbris L., Warren R.B. et al. Association between psoriasis and inflammatory bowel disease: a Danish nationwide cohort study // British Journal of Dermatology. (2016) 175, pp. 487-492. DOI 10.1111/bjd.14528.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Puzyrev V.P. Genetic basis of comorbidity in humans. Genetics. 2015. Vol. 51. No. 4. P. 491—502. DOI: 10.7868/S0016675815040098</mixed-citation><mixed-citation xml:lang="ru">Пузырев В.П. Генетические основы коморбидности у человека // Генетика. 2015. Том 51. № 4. С. 491-502. DOI: 10.7868/S0016675815040098.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and the risk of diabetes mellitus:a systematic review and meta-analysis. JAMA Dermatol. 2013;149(1):84—91. doi: 10.1001/2013.jamadermatol.406.</mixed-citation><mixed-citation xml:lang="ru">Puzyrev V.P. Genetic basis of comorbidity in humans // Genetics. 2015. Vol. 51. No. 4. P. 491-502. DOI: 10.7868/S0016675815040098.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Horreau C, Pouplard C, Brenaut E. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol. 2013 Aug; 27 Suppl 3:12—29. doi: 10.1111/jdv.12163.</mixed-citation><mixed-citation xml:lang="ru">Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and the risk of diabetes mellitus:a systematic review and meta-analysis // JAMA Dermatol. 2013;149(1):84-91. doi: 10.1001/2013.jamadermatol.406.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Dogan S, Atakan N. Psoriasis: A Disease of Systemic Inflammation with Comorbidities. In: Lima H, editor. Psoriasis — Types, Causes and Medication. InTech; 2013. http://www.intechopen.com/books/psoriasis-types-causes-and-medication/psoriasis-a-disease-of-systemic-inflammation-with-comorbidities.</mixed-citation><mixed-citation xml:lang="ru">Horreau C, Pouplard C, Brenaut E. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review // J Eur Acad Dermatol Venereol. 2013 Aug; 27 Suppl 3:12-29. doi: 10.1111/ jdv.12163.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Jing-Ji Jin, San-Wu Zeng. Association between psoriasis and metabolic syndrome: a meta-analysis from 12 case control studies. Int J Clin Exp Med. 2016;9(9):17933—17939.</mixed-citation><mixed-citation xml:lang="ru">Dogan S, Atakan N. Psoriasis: A Disease of Systemic Inflammation with Comorbidities. In: Lima H, editor. Psoriasis - Types, Causes and Medication. InTech; 2013. http://www.intechopen.com/books/psoriasis-types-causes-and-medication/psoriasis-a-disease-of-systemic-inflammation-with-comorbidities.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Spehr C, Reich K, Mrowietz U, Radtke MA, ThaciD, Rustenbach SJ, Augustin M. Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest. Arch Dermatol Res. 2015; 307(10): 875—883.</mixed-citation><mixed-citation xml:lang="ru">Jing-Ji Jin, San-Wu Zeng. Association between psoriasis and metabolic syndrome: a meta-analysis from 12 case control studies // Int J Clin Exp Med. 2016;9(9):17933-17939.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Mehta NN, Yu Y, Pinnelas R, Krishnamoorthy P, Shin DB, Troxel AB, et al. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med. 2011;124:775.e1-6.</mixed-citation><mixed-citation xml:lang="ru">Spehr C, Reich K, Mrowietz U, Radtke MA, ThaciD, Rustenbach SJ, Augustin M Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest // Arch Dermatol Res. 2015; 307(10): 875-883.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Roubille C, et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 2015;74:480—489. doi: 10.1136/annrheumdis-2014-206624.</mixed-citation><mixed-citation xml:lang="ru">Mehta NN, Yu Y, Pinnelas R, Krishnamoorthy P, Shin DB, Troxel AB, et al. Attributable risk estimate of severe psoriasis on major cardiovascular events // Am J Med. 2011;124:775.e1-6.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Oliveira MFSP, Rocha BO, Duarte GV Psoriasis: classical and emerging comorbidities. An Bras Dermatol. 2015; 90(1):09—20. DOI: http://dx.doi.org/10.1590/abd1806-4841.20153038.</mixed-citation><mixed-citation xml:lang="ru">Roubille C, et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis // Ann Rheum Dis 2015;74:480-489. doi: 10.1136/annrheumdis-2014-206624.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Armstrong AW. Do TNF inhibitors reduce the risk of myocardial infarction in psoriasis patients? JAMA. 2013 May 15;309(19):2043—4. doi: 10.1001/jama.2013.4695.</mixed-citation><mixed-citation xml:lang="ru">Oliveira MFSP, Rocha BO, Duarte GV Psoriasis: classical and emerging comorbidities // An Bras Dermatol. 2015;90(1):09-20. DOI: http://dx.doi.org/10.1590/ abd1806-4841.20153038.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Wang Y, Gao H, Loyd CM, et al. Chronic skin-specific inflammation promotes vascular inflammation and thrombosis. J Invest Dermatol. 2012 Aug;132(8):2067—75. doi: 10.1038/jid.2012.112.</mixed-citation><mixed-citation xml:lang="ru">Armstrong AW. Do TNF inhibitors reduce the risk of myocardial infarction in psoriasis patients? // JAMA. 2013 May 15;309(19):2043-4. doi: 10.1001/jama.2013.4695.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Feldman SR, Zhao Y, Shi L, Tran MH. Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis. J Manag Care Spec Pharm. 2015 Oct; 21(10):874—88.</mixed-citation><mixed-citation xml:lang="ru">Wang Y, Gao H, Loyd CM, et al. Chronic skin-specific inflammation promotes vascular inflammation and thrombosis // J Invest Dermatol. 2012 Aug;132(8):2067-75. doi: 10.1038/jid.2012.112.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><mixed-citation>Feldman SR, Zhao Y, Shi L, Tran MH. Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis // J Manag Care Spec Pharm. 2015 Oct;21(10):874-88.</mixed-citation></ref></ref-list></back></article>
